Intercept Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 41 U.S.-traded ETFs. ICPT has around 3.8M shares in the U.S. ETF market. The largest ETF holder of ICPT is the SPDR S&P Biotech ETF (XBI), with approximately 919.53K shares. Investors may also find of interest that the ETF with the largest allocation to ICPT stock is First Trust NYSE Arca Biotechnology Index Fund (FBT), with a portfolio weight of 4.64%. On average, U.S. ETFs allocate 0.45% of ICPT to their portfolios.
Additionally, ICPT is a favorite stock for Vanilla and Equal ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ICPT as a holding is the Principal Healthcare Innovators Index ETF (BTEC), with a return of 17.23%.